SIR: Ankylosing spondylitis and reactive arthritis, a form of sterile joint inflammation triggered by an infection elsewhere in the body, belong to a family of seronegative spondyloarthropathies. Reactive arthritis can follow enteric infections caused by salmonella, shigella, campylobacter, or Yersinia enterocolitica, urogenital infection caused by chlamydia, and, possibly also, infections caused byBorrelia burgdorferi, among others. ' About 80% of patients with reactive arthritis carry the HLA-B27 antigen. The mechanism of this disease is not known, but non-specific inflammatory reactions of the host with increased generation ofinflammatory mediators or increased responsiveness to them may play a part.2 For instance, subjects with previous yersinia triggered reactive arthritis show enhanced neutrophil chemotaxis3 and increased oxygen radical production.4 Neutrophil activating peptide 1/ interleukin 8 (NAP-1/IL-8) is a newly characterised chemotactic cytokine, produced by stimulated mononuclear phagocytes and a variety of tissue cells.5 Production of NAP-l/ IL-8 may be induced by microbial antigens, which were recently found in the inflamed joints of patients with reactive arthritis triggered by chlamydia,6 yersinia,7 or salmonella.t To find out whether subjects susceptible to the development of reactive arthritis show aberrant production ofcytokines we compared NAP-1/IL-8 production by monocytes of subjects with previous yersinia arthritis, uncomplicated yersinia enteritis, and without a history of yersinia infection.
Subjects were allocated to five groups (I-V, table 1) on the basis of HLA-B27, previous yersinia triggered reactive arthritis (yersinia arthritis), and previous uncomplicated yersinia enteritis. Twenty one subjects with previous yersinia arthritis were selected from a follow up patient group,9 nine subjects with previous non-complicated yersinia enteritis had been treated at the Helsinki University Central Hospital, and 24 subjects without a history of yersinia infection were healthy laboratory and hospital personnel. Diagnosis of yersinia infection was based on a stool culture positive for the organism or a raised agglutination antibody titre (>1/160) for Yersinia entero- Letters to the editor antigen was detected as long as three and 17 years after yersinia infection,7 suggesting that the microbial structures can persist in the tissues. The antigens are found in mesenteric and cervical lymph nodes and in the skin," and, during the acute phase of infection, in peripheral blood cells of almost every patient, including patients who will not develop reactive arthritis.'2 Thus the presence of antigens in the blood provides an explanation for extensive antigen dissemination, but not for the development of reactive arthritis and other clinically significant extraintestinal manifestations.
Possibly, extraintestinal symptoms derive from inflammatory hyperreactivity of the patient to the antigenic stimulus. It has been reported that neutrophils of HLA-B27 positive subjects without a history of yersinia infection and of patients with previous yersinia reactive arthritis show enhanced neutrophil migration in response to a chemotactic stimulus in vitro3 and in vivo,3 as do patients with ankylosing spondylitis, at least in vitro."' Furthermore, neutrophils from patients who have a history of severe actue yersinia triggered reactive arthritis,'5 or with sequelae,4 show increased generation of oxygen radicals in vitro. NAP-l/ IL-8 stimulates neutrophil chemotaxis and oxygen radical production5 and might thereby contribute to the neutrophil hyperactivity.
In conclusion, the results show that both control and lipopolysaccharide induced NAP-1/IL-8 production by monocytes was similar in subjects with past yersinia arthritis or enteritis and unaffected subjects, and did not differ between HLA-B27 positive and negative subjects. This seems to rule out an aberrant function ofmonocytes, at least for the synthesis and release of NAP-1/IL-8, one of their major products, in the triggering of reactive arthritis. 
